Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Darrell White, MD
Nova Scotia Cancer Centre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre - Calgary
Calgary, Alberta, Canada
- Cross Cancer Institute at University of Alberta
Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Moncton Hospital
Moncton, New Brunswick, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
- London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada
- Algoma District Cancer Program at Sault Area Hospital
Sault Ste. Marie, Ontario, Canada
- Humber River Regional Hospital - Weston
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Hopital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Hopital Notre-Dame Du Chum
Montreal, Quebec, Canada
- Mcgill Cancer Centre at Mcgill University
Montreal, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Mar 2006
- Primary completion
- 30 Jun 2008
- Completion
- 30 Jun 2008
- Last update posted
- 4 Aug 2023
- Registered enrollment
- 51
- Registry id
- NCT00305812
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.